Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher

Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher






Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher NUTRA PHARMA CRP closed unchanged at 0.018. Volume was 24% below average (neutral) and Bollinger Bands were 105% wider than normal. Open High Low Close Volume___ 0.017 0.019 0.015 0.018 814,776 Technical Outlook Short Term: Overbought Intermediate Term: Bullish Long Term: Bullish Moving Averages: 10-period 50-period 200-period Close: […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out

Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out






Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out NUTRA PHARMA CRP closed up 0.002 at 0.014. Volume was 18% below average (neutral) and Bollinger Bands were 16% wider than normal. Open High Low Close Volume___ 0.011 0.014 0.011 0.014 665,534 Technical Outlook Short Term: Neutral Intermediate Term: Bullish Long Term: Bullish Moving Averages: 10-period 50-period […]






Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care Business






Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care Business Millions of pets suffer from acute or chronic pain. While acute pain is a normal sensation triggered in the nervous system to alert your pet of possible injury and the need to take it easy, chronic pain is different, chronic pain persists. […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis

Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis






Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis This is an interesting BioTech, Nutra Pharma Corp. (OTCMKTS:NPHC) the company has drug candidates in HIV and Multiple Sclerosis as well as an existing Pain Management product. ReceptoPharm (website) is the Nutra Pharma holding that acts as the drug discovery arm for the Company. Nutra […]






Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis

Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis






Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis Nutra Pharma Corporation (OTCQB:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced a manufacturing alliance today with Omnia Biologics to […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Treatment of HIV, Arthritis, MS

Nutra Pharma Corp. (OTCMKTS:NPHC) Treatment of HIV, Arthritis, MS






Nutra Pharma Corp. (OTCMKTS:NPHC) Treatment of HIV, Arthritis, MS Nutra Pharma, through its subsidiary ReceptoPharm, has a pipeline of biopharmaceutical products under development. These research and development pipeline products consist of several novel therapies in various stages of development to prevent and/or treat multiple sclerosis, HIV/AIDS, adrenomyeloneuropathy, herpes, rheumatoid arthritis and pain. Nutra Pharma Corp. […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Major General Dowd Joins the Team

Nutra Pharma Corp. (OTCMKTS:NPHC) Major General Dowd Joins the Team






Nutra Pharma Corp. (OTCMKTS:NPHC) Major General Dowd Joins the Team Maj. Gen. Kenneth Dowd, US Army (Ret.) has joined NPHC as Strategic Advisor for the Company’s newly created ‘Military & Veterans’ business segment. General Dowd will support Nutra Pharma’s efforts in presenting the Company’s non-opiate, non-narcotic over-the-counter (OTC) pain solution, Nyloxin® to the US Military […]






Natural Pain Relief Nutra Pharma Corp. (OTCMKTS:NPHC)

Natural Pain Relief Nutra Pharma Corp. (OTCMKTS:NPHC)






Natural Pain Relief Nutra Pharma Corp. (OTCMKTS:NPHC) Millions suffer from acute or chronic pain every year and the effects of pain exact a tremendous cost on our country in health care costs, rehabilitation and lost worker productivity, as well as the emotional and financial burden it places on patients and their families. While acute pain […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Prescription Free Pain Management






Nutra Pharma Corp. (OTCMKTS:NPHC) Prescription Free Pain Management Millions suffer from acute or chronic pain every year and the effects of pain exact a tremendous cost on our country in health care costs, rehabilitation and lost worker productivity, as well as the emotional and financial burden it places on patients and their families. While acute […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Herpes, Arthritis, Multiple Sclerosis

Nutra Pharma Corp. (OTCMKTS:NPHC) Herpes, Arthritis, Multiple Sclerosis






Nutra Pharma Corp. (OTCMKTS:NPHC) Herpes, Arthritis, Multiple Sclerosis Nutra Pharma, through its subsidiary ReceptoPharm, has a pipeline of biopharmaceutical products under development. These research and development pipeline products consist of several novel therapies in various stages of development to prevent and/or treat multiple sclerosis, HIV/AIDS, adrenomyeloneuropathy, herpes, rheumatoid arthritis and pain. ReceptoPharm conducts research into […]






Nutra Pharma Corp. (OTCMKTS:NPHC) a Bargain

Nutra Pharma Corp. (OTCMKTS:NPHC) a Bargain






Nutra Pharma Corp. (OTCMKTS:NPHC) a Bargain Currently, Nutra Pharma offers several drug products for sale for the treatment of pain: Nyloxin®, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain, and Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Nyloxin® is […]






Facebook Inc (NASDAQ:FB) Trading Alert

Facebook Inc (NASDAQ:FB) Trading Alert






Facebook Inc (NASDAQ:FB) Trading Alert Overall, the bias in prices is: Upwards. Short term: Prices are stalling. Intermediate term: Prices are trending. Note: this chart shows extraordinary price action to the upside. By the way, prices are vulnerable to a correction towards 118.11. The projected upper bound is: 129.05. The projected lower bound is: 120.95. […]






Facebook Inc (NASDAQ:FB) Keeps Moving Higher

Facebook Inc (NASDAQ:FB) Keeps Moving Higher






Facebook Inc (NASDAQ:FB) Keeps Moving Higher Facebook Inc (NASDAQ:FB) technicals a re strong but Momentum Indicators are starting to flash sell. Overall, the bias in prices is: Upwards. Short term: Prices are moving. Intermediate term: Prices are trending. Note: this chart shows extraordinary price action to the upside. By the way, prices are vulnerable to […]






Facebook Inc (NASDAQ:FB) Trading Outlook

Facebook Inc (NASDAQ:FB) Trading Outlook






Facebook Inc (NASDAQ:FB) Trading Outlook FACEBOOK INC A closed down -1.220 at 123.090. Volume was 100% below average (consolidating) and Bollinger Bands were 19% wider than normal. Open High Low Close Volume___ 124.060 124.800 122.070 123.090 35,443 Technical Outlook Short Term: Neutral Intermediate Term: Bullish Long Term: Bullish Moving Averages: 10-period 50-period 200-period Close: 122.61 […]






Facebook Inc (NASDAQ:FB) Trading Outlook

Facebook Inc (NASDAQ:FB) Trading Outlook






Facebook Inc (NASDAQ:FB) Trading Outlook FACEBOOK INC A closed down -1.310 at 120.610. Volume was 27% below average (neutral) and Bollinger Bands were 34% wider than normal. Open High Low Close Volume___ 121.920 122.100 120.250 120.610 17,801,664 Technical Outlook Short Term: Overbought Intermediate Term: Bullish Long Term: Bullish Moving Averages: 10-period 50-period 200-period Close: 118.65 […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Move Higher

Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Move Higher






Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Move Higher Candlesticks reflect positive action A big white candle occurred. This is generally considered bullish, as prices closed significantly higher than they opened. If the candle appears when prices are “low,” it may be the first sign of a bottom. If it occurs when prices are rebounding off […]






HEFFX Initiates Coverage on Nutra Pharma Corp. (OTCMKTS:NPHC)

HEFFX Initiates Coverage on Nutra Pharma Corp. (OTCMKTS:NPHC)






HEFFX Initiates Coverage on Nutra Pharma Corp. (OTCMKTS:NPHC) On the surface this one looks interesting and we will be digging around to see if NPHC represents an opportunity or is just another sub-penny shocker. Nutra Pharma Corp. is a biopharmaceutical company. The Company is engaged in the acquisition, licensing and commercialization of pharmaceutical products and […]






Facebook Inc (NASDAQ:FB) Trading Outlook Dead Cat Bounce?

Facebook Inc (NASDAQ:FB) Trading Outlook Dead Cat Bounce?






Facebook Inc (NASDAQ:FB) Trading Outlook Dead Cat Bounce? FACEBOOK INC A closed down -3.110 at 108.970. Volume was 99% below average (consolidating) and Bollinger Bands were 5% wider than normal. Open High Low Close Volume___ 111.570 111.570 108.230 108.970 130,125 Technical Outlook Short Term: Neutral Intermediate Term: Bearish Long Term: Bullish Moving Averages: 10-period 50-period […]






Facebook Inc (NASDAQ:FB) to Trade Sub $100

Facebook Inc (NASDAQ:FB) to Trade Sub $100






Facebook Inc (NASDAQ:FB) to Trade Sub $100 FACEBOOK INC A closed down -0.340 at 114.600. Volume was 29% below average (neutral) and Bollinger Bands were 49% narrower than normal. Open High Low Close Volume___ 115.300 115.440 114.070 114.600 19,819,432 Technical Outlook Short Term: Neutral Intermediate Term: Bearish Long Term: Bullish Moving Averages: 10-period 50-period 200-period […]






Facebook Inc (NASDAQ:FB) Trading Outlook

Facebook Inc (NASDAQ:FB) Trading Outlook






Facebook Inc (NASDAQ:FB) Trading Outlook FACEBOOK INC A closed down -2.670 at 113.950. Volume was 10% above average (neutral) and Bollinger Bands were 60% narrower than normal. Open High Low Close Volume___ 115.000 115.480 113.310 113.950 31,718,240 Technical Outlook Short Term: Neutral Intermediate Term: Bearish Long Term: Bullish Moving Averages: 10-period 50-period 200-period Close: 117.91 […]






Facebook Inc (NASDAQ:FB) is Killing Twitter Inc (NYSE:TWTR)

Facebook Inc (NASDAQ:FB) is Killing Twitter Inc (NYSE:TWTR)






Facebook Inc (NASDAQ:FB) is Killing Twitter Inc (NYSE:TWTR)   Facebook Inc (NASDAQ:FB) owned Instagram is now being utilized more than Twitter in social media advertising campaigns, according the most recent Advertising Agency Survey by STRATA, a Comcast Platform Services company. While Facebook and YouTube maintain their top positions (96% and 67% of agencies plan on […]






Facebook Inc (NASDAQ:FB) is Outperforming Through Innovation

Facebook Inc (NASDAQ:FB) is Outperforming Through Innovation






Facebook Inc (NASDAQ:FB) is Outperforming Through Innovation Yes, I know that I have never been a Facebook fan, the stock still looks overvalued to me, however the company and Zuckerberg are delivering in terms of growth and innovation. Innovation is something lacking in the “Unicorn Stocks” but I am always happy to admit when I […]






Facebook Inc (NASDAQ:FB) a New Force in News

Facebook Inc (NASDAQ:FB) a New Force in News






Facebook Inc (NASDAQ:FB) a New Force in News Facebook remains overvalued and I would not buy the stock, but the company does continue to deliver in surprising areas. Now Facebook are taking over news. Facebook Inc (NASDAQ:FB) is fast becoming a primary news source for almost half of American adults. The Pew Research Center survey […]






Alibaba Group Holding Ltd (NYSE:BABA) Trading Update

Alibaba Group Holding Ltd (NYSE:BABA) Trading Update






Alibaba Group Holding Ltd (NYSE:BABA) Trading Update ALIBABA GRP ADR closed down -0.090 at 75.820. Volume was 74% below average (consolidating) and Bollinger Bands were 47% narrower than normal. Open High Low Close Volume___ 75.640 75.910 75.010 75.820 3,319,677 Technical Outlook Short Term: Neutral Intermediate Term: Bearish Long Term: Bullish Moving Averages: 10-period 50-period 200-period […]